Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Merck's cash to debt ratio for the quarter that ended in Jun. 2022 was 0.32.
If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Merck couldn't pay off its debt using the cash in hand for the quarter that ended in Jun. 2022.
The historical rank and industry rank for Merck's Cash-to-Debt or its related term are showing as below:
MRK'
s Cash-to-Debt Range Over the Past 10 Years
Min: 0.22 Med: 0.64 Max: 6.12
Current: 0.32
During the past 13 years, Merck's highest Cash to Debt Ratio was 6.12. The lowest was 0.22. And the median was 0.64.
MRK's Cash-to-Debt is ranked worse than 71.05% of 1088
companies
in the Drug Manufacturers industry
Industry Median: 1.07
vs MRK: 0.32
Merck Cash-to-Debt Historical Data
The historical data trend for Merck's Cash-to-Debt can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Merck Annual Data
Trend
Dec12
Dec13
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Cash-to-Debt
0.35
0.35
0.40
0.25
0.25
Merck Quarterly Data
Sep17
Dec17
Mar18
Jun18
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Cash-to-Debt
0.32
0.38
0.25
0.28
0.32
Competitive Comparison
For the Drug Manufacturers - General subindustry, Merck's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Merck Cash-to-Debt Distribution
For the Drug Manufacturers industry and Healthcare sector, Merck's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where Merck's Cash-to-Debt falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Merck (NYSE:MRK) Cash-to-Debt Explanation
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
Merck Cash-to-Debt Related Terms
Thank you for viewing the detailed overview of Merck's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to half of the firm's sales are generated in the United States.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
0.01(0.01%) Volume: 5,661,169 4:05PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NYSE:MRK has been successfully added to your 
